Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) for the treatment of newly diagnosed AL amyloidosis: Impact of response on survival outcomes
Diaz-Pallares, Carolina, Lee, Holly, Luider, Joanne, Duggan, Peter, Neri, Paola, Tay, Jason, MacCulloch, Sylvia, Bahlis, Nizar J., Jimenez-Zepeda, Victor H.Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2019.11.005
Date:
November, 2019
File:
PDF, 2.50 MB
english, 2019